Electronic Sequencing in Nanopores
纳米孔中的电子测序
基本信息
- 批准号:7898057
- 负责人:
- 金额:$ 74.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-13 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAchievementAdvanced DevelopmentAnodesBindingCarbonCarbon NanotubesCellsChemicalsComputer softwareConfidential InformationDNADNA ProbesDNA SequenceDataDevicesDiagnosisDisclosureDiseaseEcologyElectrodesElectronicsEnvironmentEvolutionFigs - dietaryFreedomFundingFutureGenerationsGenomeGenomicsGoalsGovernmentGrantHealthHeartHourHousingHumanHuman GeneticsInvestmentsKnowledgeLabelLegal patentLengthMembraneModelingMolecularMotionNanotechnologyNanotubesNational Human Genome Research InstituteNucleotidesOperative Surgical ProceduresPatternProceduresPropertyReadingResearch ProposalsRouteServicesSideSignal TransductionSiliconSingle-Stranded DNASlideSolutionsStructureSurfaceSystemThickTimeUnited StatesUnited States National Institutes of HealthVisionWaterWorkbasecostdesigndetectordisorder preventionelectrical propertyexperienceimprovedinstrumentinterestmammalian genomenanoporenanoscaleprogramsremediationresearch and developmentresearch studyresponsesensorsilicon nitridesingle moleculesingle walled carbon nanotubesolid statesoundvoltage
项目摘要
DESCRIPTION (provided by applicant): The long-term objective is a nanopore detector chip for a general utility instrument capable of inexpensive de novo sequencing that can also be used for re-sequencing projects. The instrument directly generates base-dependent electronic signals as multi-kilobase length fragments of single stranded genomic DNA is driven sequentially through nanopores articulated with electrically contacted single walled carbon nanotube probes. The final system is intended to provide a relatively high quality sequence from =6.5-fold coverage of a genome using DNA from fewer than 1 million cells, with no amplification or labeling. The specific aims are: 1) Characterize ungapped nanotube articulated nanopore detectors in ionic solution with and without DNA molecules to establish a device model; 2) Control ssDNA binding, translocation, and sliding on the nanotube surface exposed in ungapped nanotube articulated nanopores; 3) Study and optimize DNA molecule induced field effect modulation of nanotube electrode conductance in ungapped nanotube articulated nanopores as a function of nanotube bias, gate voltage, and solution properties; 4) Analyze and optimize tunneling current modulations between gapped nanotube electrodes in the first generation detector; 5) Design and fabricate a second generation detector with embedded 'T' nanotube geometry and achieve 1 Kb/sec sequencing on Kb length strands of DNA; 6) Design a third generation nanopore detector for high throughput 10 Kb/sec/nanopore sequencing. If we are able to resolve each base as it passes through a nanopore at the rate of 104 bases/sec as proposed here, an instrument with an array of 100 such nanopores could produce a high quality draft sequence of one mammalian genome in ~20 hours at a cost of approximately $1,000/mammalian genome. Genomic sequencing at these reduced costs would make vital contributions to improved human health on many fronts, including the understanding, diagnosis, treatment, and prevention of disease; environmental science and remediation; and the genetics of human health and disease derived from the understanding of evolution. PROJECT HEALTH RELEVANCE We are developing the core detector of an instrument that could produce a high-quality draft sequence of one mammalian genome in ~20 hours at a cost of approximately $1,000/mammalian genome. Genomic sequencing at these reduced costs would make vital contributions to improved human health on many fronts, including the understanding, diagnosis, treatment, and prevention of disease; environmental science and remediation; and the genetics of human health and disease derived from the understanding of evolution.
描述(由申请人提供):长期目标是一种纳米孔检测器芯片,用于能够廉价的从头测序的通用仪器,也可以用于重新续签项目。该仪器直接生成基础依赖性电子信号,因为单链基因组DNA的多吉尔酶长度片段被依次通过用电接触的单壁碳纳米管探针表达的纳米孔驱动。最终系统旨在使用少于100万个细胞的DNA提供相对较高的质量序列,而没有扩增或标记。具体目的是:1)表征没有DNA分子和不具有DNA分子的离子溶液中未媒体的纳米管铰接式纳米孔检测器来建立设备模型; 2)控制ssDNA的结合,易位和滑动在未封闭的纳米管铰接式纳米孔中暴露的纳米管表面上; 3)研究并优化了未模拟的纳米管铰接式纳米孔中纳米管电极电导电极电导率的现场效应调制,这是纳米管偏置,栅极电压和溶液特性的函数; 4)分析和优化第一代检测器中含量纳米管电极之间的隧道电流调制; 5)用嵌入的“ T”纳米管几何形状设计和制造第二代探测器,并在DNA的Kb长度链上实现1 kb/sec的测序; 6)设计第三代纳米孔检测器,用于高吞吐量10 kb/sec/纳米孔测序。如果我们能够以这里提出的104个碱基/秒的速度通过纳米孔时解决每个碱基,那么这种纳米孔的数组可能会在20小时内以大约20小时的成本产生一个高质量的纳米孔序列,以大约1,000美元/哺乳动物的基因组产生一个高质量的草稿序列。以这些降低的成本进行基因组测序将对改善许多方面的人类健康做出至关重要的贡献,包括对疾病的理解,诊断,治疗和预防;环境科学和补救;人类健康和疾病的遗传学源于对进化的理解。 项目健康相关性我们正在开发一种仪器的核心探测器,该仪器可以在约20小时内产生一个哺乳动物基因组的高质量草稿序列,成本约为1,000美元/哺乳动物的基因组。以这些降低的成本进行基因组测序将对改善许多方面的人类健康做出至关重要的贡献,包括对疾病的理解,诊断,治疗和预防;环境科学和补救;人类健康和疾病的遗传学源于对进化的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL none BRANTON其他文献
DANIEL none BRANTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL none BRANTON', 18)}}的其他基金
相似国自然基金
共和盆地东北部地区隆升剥蚀过程对干热岩形成就位的影响:来自低温热年代学的制约
- 批准号:42202336
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
朱鹮野生种群营养生态位对繁殖成就的影响及保护对策研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
朱鹮野生种群营养生态位对繁殖成就的影响及保护对策研究
- 批准号:32270554
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
共和盆地东北部地区隆升剥蚀过程对干热岩形成就位的影响:来自低温热年代学的制约
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成就目标视角下建言韧性的形成机制与作用效果研究
- 批准号:72102228
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of Tumor and Immuno-Metabolism Based Small Molecule Therapeutics for Refractory Breast Cancer
基于肿瘤和免疫代谢的难治性乳腺癌小分子疗法的发展
- 批准号:
10266156 - 财政年份:2020
- 资助金额:
$ 74.52万 - 项目类别: